Trends in medical use and abuse of opioid analgesics - PubMed (original) (raw)
Trends in medical use and abuse of opioid analgesics
D E Joranson et al. JAMA. 2000.
Abstract
Context: Pain often is inadequately treated due in part to reluctance about using opioid analgesics and fear that they will be abused. Although international and national expert groups have determined that opioid analgesics are essential for the relief of pain, little information has been available about the health consequences of the abuse of these drugs.
Objective: To evaluate the proportion of drug abuse related to opioid analgesics and the trends in medical use and abuse of 5 opioid analgesics used to treat severe pain: fentanyl, hydromorphone, meperidine, morphine, and oxycodone.
Design and setting: Retrospective survey of medical records from 1990 to 1996 stored in the databases of the Drug Abuse Warning Network (source of abuse data) and the Automation of Reports and Consolidated Orders System (source of medical use data).
Patients: Nationally representative sample of hospital emergency department admissions resulting from drug abuse.
Main outcome measures: Medical use in grams and grams per 100,000 population and mentions of drug abuse by number and percentage of the population.
Results: From 1990 to 1996, there were increases in medical use of morphine (59%; 2.2 to 3.5 million g), fentanyl (1168%; 3263 to 41,371 g), oxycodone (23%; 1.6 to 2.0 million g), and hydromorphone (19%; 118,455 to 141,325 g), and a decrease in the medical use of meperidine (35%; 5.2 to 3.4 million g). During the same period, the total number of drug abuse mentions per year due to opioid analgesics increased from 32,430 to 34,563 (6.6%), although the proportion of mentions for opioid abuse relative to total drug abuse mentions decreased from 5.1% to 3.8%. Reports of abuse decreased for meperidine (39%; 1335 to 806), oxycodone (29%; 4526 to 3190), fentanyl (59%; 59 to 24), and hydromorphone (15%; 718 to 609), and increased for morphine (3%; 838 to 865).
Conclusions: The trend of increasing medical use of opioid analgesics to treat pain does not appear to contribute to increases in the health consequences of opioid analgesic abuse.
Comment in
- Reporting drug abuse in the emergency department.
Ball J, Korper S, Woodward A. Ball J, et al. JAMA. 2000 Aug 2;284(5):564. doi: 10.1001/jama.284.5.564. JAMA. 2000. PMID: 10918695 No abstract available.
Similar articles
- Assessment of the trends in medical use and misuse of opioid analgesics from 2004 to 2011.
Atluri S, Sudarshan G, Manchikanti L. Atluri S, et al. Pain Physician. 2014 Mar-Apr;17(2):E119-28. Pain Physician. 2014. PMID: 24658483 - A reassessment of trends in the medical use and abuse of opioid analgesics and implications for diversion control: 1997-2002.
Gilson AM, Ryan KM, Joranson DE, Dahl JL. Gilson AM, et al. J Pain Symptom Manage. 2004 Aug;28(2):176-88. doi: 10.1016/j.jpainsymman.2004.01.003. J Pain Symptom Manage. 2004. PMID: 15276196 - Trends in medical use and abuse of sustained-release opioid analgesics: a revisit.
Novak S, Nemeth WC, Lawson KA. Novak S, et al. Pain Med. 2004 Mar;5(1):59-65. doi: 10.1111/j.1526-4637.2004.04001.x. Pain Med. 2004. PMID: 14996238 - Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J, Böger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P. Pergolizzi J, et al. Pain Pract. 2008 Jul-Aug;8(4):287-313. doi: 10.1111/j.1533-2500.2008.00204.x. Epub 2008 May 23. Pain Pract. 2008. PMID: 18503626 - Palliative Treatment of Cancer-Related Pain [Internet].
Kongsgaard U, Kaasa S, Dale O, Ottesen S, Nordøy T, Hessling SE, von Hofacker S, Bruland ØS, Lyngstadaas A. Kongsgaard U, et al. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005 Dec. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 09-2005. Oslo, Norway: Knowledge Centre for the Health Services at The Norwegian Institute of Public Health (NIPH); 2005 Dec. Report from Norwegian Knowledge Centre for the Health Services (NOKC) No. 09-2005. PMID: 29320015 Free Books & Documents. Review.
Cited by
- The opioid industry's use of scientific evidence to advance claims about prescription opioid safety and effectiveness.
Gupta R, Chernesky J, Lembke A, Michaels D, Tomori C, Greene JA, Alexander GC, Koon AD. Gupta R, et al. Health Aff Sch. 2024 Oct 24;2(10):qxae119. doi: 10.1093/haschl/qxae119. eCollection 2024 Oct. Health Aff Sch. 2024. PMID: 39450313 Free PMC article. - An Overview of Opioid Prescription Patterns among Non-Opioid Users Following Emergency Department Admission.
Zeino M, Léguillon R, Brevet P, Gerard B, Chenailler C, Raymond J, Bibaut L, Pouplin S, Joly LM, Varin R, Barat E. Zeino M, et al. Healthcare (Basel). 2024 Jun 3;12(11):1138. doi: 10.3390/healthcare12111138. Healthcare (Basel). 2024. PMID: 38891213 Free PMC article. - Fentanyl and its derivatives: Pain-killers or man-killers?
Patocka J, Wu W, Oleksak P, Jelinkova R, Nepovimova E, Spicanova L, Springerova P, Alomar S, Long M, Kuca K. Patocka J, et al. Heliyon. 2024 Mar 28;10(8):e28795. doi: 10.1016/j.heliyon.2024.e28795. eCollection 2024 Apr 30. Heliyon. 2024. PMID: 38644874 Free PMC article. Review. - Treatment Patterns and Population Characteristics of Nonpharmacological Management of Chronic Pain in the United States' Medicare Population: A Scoping Review.
Choudry E, Rofé KL, Konnyu K, Marshall BDL, Shireman TI, Merlin JS, Trivedi AN, Schmidt C, Bhondoekhan F, Moyo P. Choudry E, et al. Innov Aging. 2023 Aug 11;7(10):igad085. doi: 10.1093/geroni/igad085. eCollection 2023. Innov Aging. 2023. PMID: 38094932 Free PMC article. Review. - Nalbuphine May Be Superior to Sufentanil in Relieving Postcesarean Uterine Contraction Pain in Multiparas: A Retrospective Cohort Study.
Zheng K, Chen B, Sun J. Zheng K, et al. Drug Des Devel Ther. 2023 May 8;17:1405-1415. doi: 10.2147/DDDT.S394664. eCollection 2023. Drug Des Devel Ther. 2023. PMID: 37188281 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical